Latest News
Latest News
News & Press
Scientific Advancements
- CONTEMPORARY HEALTH SYSTEMS Announces the USPTO has issued a Patent5 February 2026, 3:39 pm
CONTEMPORARY HEALTH SYSTEMS Announces the USPTO has issued a Patent for its Biomarker Assessment of Olfactory and Gustatory Functioning for Detection andMonitoring of multiple neurological diseases and downstream medical conditionsWEST...
- Alabama biotech startup identifies fucose modulation as promising improvement to antibody therapies30 October 2025, 8:44 pm
HUNTSVILLE (October 30, 2025) – Scientists at Score Pharma, a therapeutics company located on the HudsonAlpha Institute for Biotechnology campus, believe they’ve found a way to make existing antibodytherapies for...
- Cadrenal Therapeutics Announces Clinical Trial Initiation Plans for Tecarfarin in Patients with End-5 August 2025, 8:15 pm
Advances knowledge about the use of tecarfarin in patients with severe kidney impairment, including dialysisPivotal step forward in pursuit of ESKD + Atrial Fibrillation (AFib) registration trialAddresses a critical current...
- Hesperos Demonstrates First Digital Twin of Human Disease Using Organ-on-a-Chip Platform23 July 2025, 3:01 pm
A landmark study in Advanced Science details what is believed to be the first digital twin derived from an organ-on-a-chip, combining multi-organ biology with PK/PD modeling to predict human drug...
- Arthrex NanoScopeâ„¢ System Receives Pediatric Clearance for Orthopedic, Laparoscopic Procedures21 July 2025, 7:41 pm
(NAPLES, Florida - July 16, 2025) — Arthrex, a global leader in minimally invasive surgical technology, announced that it has received U.S. Food and Drug Administration (FDA) clearance to use...
- Psilera Collaborates with Drug Development Leader Hesperos to Advance Preclinical Modeling of PSIL-09 June 2025, 10:01 pm
Psilera Collaborates with Drug Development Leader Hesperos to Advance Preclinical Modeling of PSIL-006 for Frontotemporal DementiaStrategic agreement underscores Psilera's commitment to advancing PSIL-006 with precision neurology approachResults are expected in...
- Cloud 9 Careâ„¢ Awarded U.S. Patent for Groundbreaking Pressure Injury Prevention System7 May 2025, 5:21 pm
FOR IMMEDIATE RELEASE Cloud 9 Care™ Awarded U.S. Patent for Groundbreaking Pressure Injury Prevention System Hillsboro, OR — May 6, 2025 —  Cloud 9 Care, a nurse-led healthcare innovation company, today...
- FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs17 April 2025, 9:45 pm
FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other DrugsFor Immediate Release:April 10, 2025Today, the U.S. Food and Drug Administration is taking a groundbreaking step...
- Pretzel Therapeutics Initiates Phase 1 Clinical Study Evaluating PX578, Lead Therapeutic in its Bioe3 April 2025, 4:26 pm
Pretzel Therapeutics Initiates Phase 1 Clinical Study Evaluating PX578, Lead Therapeutic in its Bioenergetics Restoration Franchise- First-in-class approach to targeting mitochondrial DNA polymerase (POLG) with disease modifying potential across mitochondrial...
- Medtronic reports first-ever procedures with next-gen PillCam Genius capsule endoscopy kit13 December 2024, 8:58 pm
Medtronic reports first-ever procedures with next-gen PillCam Genius capsule endoscopy kitDecember 12, 2024 By Sean WhooleyMedtronic(NYSE: MDT)+ today announced the first-ever patient procedure ingestion using its next-generation PillCam Genius SB capsule endoscopy kit. The...

